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Abstract
Introduction: Despite improved efficacy of, and access to, combination antiretroviral therapy (cART), HIV-associated cognitive
impairments remain prevalent in both children and adults. Neuropsychological tests that detect such impairment can help
clinicians formulate effective treatment plans. The Kaufman Assessment Battery for Children (KABC), although developed and
standardized in the United States, is used frequently in many different countries and cultural contexts to assess paediatric
performance across various cognitive domains. This systematic review investigated the cross-cultural utility of the original
KABC, and its 2nd edition (KABC-II), in detecting HIV-associated cognitive impairment in children and adolescents.
Methods: We entered relevant keywords and MeSH terms into the PubMed, PsycInfo, EBSCOHost, ProQuest, and Scopus
databases, with search limits set from 1983–2017. Two independent reviewers evaluated the retrieved abstracts and
manuscripts. Studies eligible for inclusion in the review were those that (a) used the KABC/KABC-II to assess cognitive
function in children/adolescents aged 2–18 years, (b) featured a definition of cognitive impairment (e.g. >2 SD below the
mean) or compared the performance of HIV-infected and uninfected control groups, and (c) used a sample excluded from
population on which the instruments were normed.
Results and discussion: We identified nine studies (eight conducted in African countries, and one in the United Kingdom) to
comprise the review’s sample. All studies detected cognitive impairment in HIV-infected children, including those who were
cART-naïve or who were cART treated and clinically stable. KABC/KABC-II subtests assessing simultaneous processing
appeared most sensitive. Evaluation of the methodological quality of the selected studies by two independent reviews
suggested that shortcomings included reporting and selection biases.
Conclusions: This systematic review provides evidence for the cross-cultural utility of the KABC/KABC-II, particularly the
simultaneous processing subtests, in detecting cognitive impairment in HIV-infected children (including those who are
clinically stable). Although the current results suggest there is justification for using the KABC/KABC-II primarily in East
Africa, further investigation is required to explore the instrument’s utility in other HIV-prevalent regions of the globe.
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Introduction
Recent global estimates suggest that 3.2 million children
under 15 years of age are living with HIV. Ninety-one per
cent (more than 2.9 million) of those children reside in Sub-
Saharan Africa [1]. The effects of HIV infection on children’s
physical growth, psychological health, and neurodevelop-
ment ranges from mild to devastating. These effects extend
to cognitive development: A wealth of evidence indicates
that HIV-infected children are likely to present with some
form of cognitive impairment, with reported deficits in
domains including attention, processing speed, language,
motor skills, learning and memory, visual-spatial abilities,
and executive functioning [2–4].
Research investigating the cognitive development of African,
Indian, Asian, European, and South American HIV-infected chil-
dren has reported a high (up to 90%) prevalence of cognitive
and neurodevelopmental delays [5–11]. Despite this state of
affairs, HIV-infected children are not routinely screened or
formally assessed for cognitive delays or deficits. Although
Boyede and colleagues [12] reported on the validation of a
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screening tool for rapid screening of moderate-to-severe global
developmental delays in HIV-infected South African children,
that tool is suitable only for those aged 9–36 months, and has
not been validated for use elsewhere. Furthermore, although
screening tools are useful in offering a basic determination of
the presence or absence of cognitive deficits, they often lack
the sensitivity and the theoretical framework required of com-
prehensive diagnostic instruments, and cannot deliver in-depth
critical analysis of potential deficits [13,14].
Clinicians weighing the appropriateness of a cognitive
measure for their particular context must consider whether
a test developed and standardized on a specific population
continues to measure the same construct when applied in a
different setting [15,16]. Measured consideration of the
cross-cultural equivalence of neuropsychological tests is
often undermined by the grim practical reality of a severe
lack of approved test material, however [17,18]. In low- and
middle-income countries (LAMICs), especially, clinical neu-
ropsychologists are hampered in their practice by a paucity
of locally developed, standardized, and normed tests [19,20].
This situation is concerning in light of the prevalence of
cultural and language differences, educational inequalities,
and socio-political disadvantages that are often present in
those countries, and that influence performance on standar-
dized measures of cognitive function [21–23].
The Kaufman Assessment Battery for Children (KABC),
and its revised second edition, the KABC-II, are measures
of intellectual functioning, developed and standardized in
the United States, with strong psychometric characteristics
[24,25]. As Figure 1 shows, the KABC and KABC-II both
assess a wide range of cognitive domains, including those
commonly affected by HIV in children. The KABC is suitable
for administration to children aged from 2 years 6 months
to 12 years 6 months, whereas the KABC-II is suitable for
children aged from 3 years 0 months to 18 years 11 months.
Each battery can be administered in 25–100 min, depend-
ing on the child’s age. Whereas the KABC was grounded in
the Horn and Cattell’s theory of crystallized versus fluid
intelligence [26], the KABC-II’s results can be interpreted
according to either Luria’s neuropsychological theory of
processing [27] or the Cattell-Horn-Carroll (CHC) psycho-
metric model [28]. What this means, in practice, is that
Figure 1. Subtests and indices comprising the KABC and KABC-II, and the cognitive abilities assessed by each. The left panel shows
subtests unique to the KABC, the right panel subtests unique to KABC-II, and the middle panel subtests common to the two. The KABC
Achievement subtests (Photo Series, Expressive Vocabulary, Faces and Places, Reading/Decoding, Arithmetic, and Riddles), and the KABC-II
Knowledge subtests (Verbal Knowledge, Expressive Knowledge, and Riddles) are shaded grey. These subtests assess crystallized knowledge.
The KABC-II Learning subtests (Atlantis, Atlantis Delayed, Rebus, and Rebus Delayed) are shaded green. These subtests assess the ability to
store and retrieve novel information. The KABC-II Planning subtests (Story Completion and Pattern Reasoning) are shaded yellow. These
subtests assess the ability to solve nonverbal problems that require high-level decision-making and reasoning abilities. The KABC/KABC-II
Sequential Processing subtests (Hand Movements, Number Recall, and Word Order) are shaded orange. These subtests assess the ability to
solve problems by coding auditory and visual information presented serially. Simultaneous Processing subtests of the KABC (Magic Window,
Matrix Analogies, Spatial Memory, Arithmetic, Triangles, Face Recognition, and Gestalt Closure) and of the KABC-II (Rover, Block Counting,
Conceptual Thinking, Triangles, Face Recognition, and Gestalt Closure) are shaded blue. These subtests assess the ability to solve spatial or
logistical problems that require the processing of many related stimuli simultaneously. Summing scores across these subtests/indices
generates a Mental Processing Index (MPI) score, which reflects the child’s overall performance on the battery. On the KABC-II, summing
scores across the Hand Movements, Block Counting, Triangles, Pattern Reasoning, Story Completion, Conceptual Thinking, and Face
Recognition subtests generates a Nonverbal Index (NVI) score. This set of subtests is used in children for whom a nonverbal measure of
cognitive functioning is deemed appropriate (e.g. those with severe speech or language deficits).
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the KABC-II measures the same abilities as the KABC, but
also measures abilities in two additional cognitive domains
(viz., Planning and Learning).
Both the KABC and KABC-II have been used across the
globe to assess cognitive functioning comprehensively
[29,30]. Their widespread use is attributable largely to the
fact that (a) they incorporate teaching items to increase
familiarity with the test materials, (b) test responses
require very little verbalization from examinees, and (c)
early psychometric studies suggested they were culture-
fair when applied to different ethnic groups within the
United States [31–33]. Subsequently, validation studies con-
ducted in Africa and Asia have demonstrated that the
instruments maintain their construct validity, and are sen-
sitive to socio-economic factors and disease effects [e.g.
34,35,36]. Furthermore, a meta-analysis of KABC validation
studies across cultures supported the factor integrity of the
distinction between the Sequential Processing versus
Simultaneous Processing indices [37]. In summary, strong
theoretical and psychometric foundations, culture-fair
assessment techniques, and cross-cultural adaptability
have positioned the KABC/KABC-II as the best-choice
instrument for researchers or clinicians who operate in a
variety of cultural contexts and who require a well-standar-
dized measure of cognitive ability within specific domains
[30,36,38].
Despite the KABC/KABC-II’s popularity, and its wide-
spread use in regions where HIV is highly prevalent (e.g.
sub-Saharan Africa), no study has formally evaluated
whether these instruments are suited to identify cognitive
impairment, across distinct and independent domains, in
HIV-infected children. (Indeed, there are currently no vali-
dated neuropsychological tests, or test batteries, designed
specifically to detect such deficits in children or in adoles-
cents.) Hence, this systematic review aimed to determine
whether the KABC/KABC-II identifies HIV-associated cogni-
tive impairment in children who reside in cultural contexts
outside of that in which the instrument was developed,
standardized, and validated.
Methods
Figure 2 is a PRISMA flowchart documenting the process by
which we arrived at the final sample of studies that met the
Database search 
PubMed = 18 PsycINFO = 6 
Scopus = 9 ProQuest = 2 
EBSCOHost = 3 
(n = 38) 
Additional records identified from 
reference lists 
(n = 28) 
Step 1: 
Identification 
Total considered for screening  
(n = 66) Step 2: Screening 
Removed duplicates 
(n = 12) 
Articles excluded, and reasons 
for exclusion 
• Sample does not include 
HIV+ children (2) 
• Did not use KABC (3) 
• No definition of HIV-
associated cognitive 
impairment (9) 
• Not a cross-cultural sample 
(4) 
• Not HIV+, and no definition 
of HIV-associated cognitive 
impairment (12) 
• Age inappropriate and no 
KABC (2) 
• Could not get full text (3) 
• Review article (6) 
• Other reasons (4) 
Records assessed for eligibility 
(n = 54) Step 3: Eligibility  
Studies included in narrative 
synthesis 
(n = 9) 
Step 4: Inclusion 
Figure 2. PRISMA flowchart documenting search process and results.
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eligibility criteria and that were included in the systematic
review. Below, we describe each stage of that process in
detail.
Search strategy
We used electronic databases (EBSCOHost, ProQuest,
PsycInfo, PubMed, and Scopus) to search for published
and unpublished studies, posters, PowerPoints, and
abstracts. The search limits were set from 1983 (the year
the KABC was published) to February 2017. Keywords were
MeSH and non-MeSH search terms covering HIV/AIDS, chil-
dren, HIV medication (e.g. HAART), KABC, and cognitive
development/functioning (see Additional File 1). The search
identified 38 studies. We then conducted a manual search
of the references from the identified articles and published
conference proceedings to ensure all relevant articles were
identified. This arm of the search strategy yielded an addi-
tional 28 articles.
Study selection
Two authors (KvW and TvdW) screened abstracts (and full
text if needed) to determine inclusion status.
Disagreements were resolved by discussion. We included
studies that met the following criteria: (1) Used a sample
that comprised HIV-infected children (who may or may not
have been on cART, and may or may not have been co-
infected); (2) used a sample consisting of children between
the ages of 2 and 18 years, inclusive; (3) used (a subtest of)
the KABC/KABC-II; (4) provided a method to indicate cogni-
tive impairment in the HIV-infected sample (e.g. compar-
ison to normative or control group, definition of
impairment provided); and (5) used a sample excluded
from the original normative data on which the KABC was
standardized (i.e. we excluded studies that used as their
samples individuals who identified as African-American,
Hispanic, American White, American Indian, Alaskan
Native, Asian-American, or Pacific Islander).
There were no exclusion criteria based on language or
format of publication. All study designs were included, with
the exception of reviews. The latter were used to search for
any other studies that could be included. If a full text was
unavailable online, we emailed the authors and followed up
weekly. If there was no response after 3 months, the article
was considered excluded/missing data. Items coded as “not
specified” (NS) indicates that we did not receive a response
(see Additional File 2).
Data extraction and quality assessment
Nine studies (seven peer-reviewed journal articles, one
poster, and one Master’s thesis) fulfilled the inclusion cri-
teria and were reviewed [39–47]. Two authors (KvW and
TvdW) performed data extraction using a spreadsheet (see
Additional File 1) based on the STROBE statement for
observational studies [48]. STROBE is a detailed checklist
developed to ensure that adequate data are extracted from
all studies (e.g. cohort, cross-sectional, case-control)
included in systematic reviews. Here, we were particularly
interested in the place of study, inclusion of confounding
variables, reporting of study limitations and strengths, and
detailed information on HIV status and KABC results. In
addition, the same two authors independently assessed
the quality of all included studies (see Table 1 and
Additional File 1) using a modified version of the Downs
and Black [49] checklist. Originally designed for the assess-
ment of the methodological quality of randomized and non-
randomized studies, the checklist consists of 26 items
representing six sub-scales: reporting, internal validity,
external validity, bias, confounding, and power. Because
none of the included studies reported power calculations
to determine whether there was an adequate sample size
to assess the ability of the KABC to determine between-
group differences, item 27 was excluded from the standard
checklist. Hence, the maximum score for the modified
checklist was 26. Again, disagreements were resolved by
discussion. Since the Downs and Black checklist does not
stipulate a cutoff for suitable studies, we used the mid-
point score of 13 to differentiate between lower- and
higher-quality studies [50].
Results and discussion
We set out to determine, via systematic review, whether a
popular, widely used, and psychometrically sound cognitive
test battery, the Kaufman Assessment Battery for Children,
identifies HIV-associated cognitive impairment in children
who reside in cultural contexts outside of that in which the
instrument was developed, standardized, and validated.
Study characteristics
As Table 1 shows, 8 of the 9 studies that formed the final
sample were conducted in Africa, where the vast majority
of HIV-infected children reside. The other study was con-
ducted in the United Kingdom. Uganda was the most repre-
sented country (five studies), followed by South Africa (two
studies, one of which was a multi-site study that also
featured data collected from Malawi, Uganda, and
Zimbabwe), England, and the Democratic Republic of the
Congo (one each). Four studies featured cross-sectional
designs, three were longitudinal, one used a prospective
design, and one was a randomized control trial.
As Table 2 shows, the studies featured a total of 1792
participants, including 720 (51%) who were HIV infected. Of
the latter participants, 329 (46%) were cART-naïve at study
initiation. Across all studies, the age range of participants
was 2–14 years (M for HIV-infected participants = 7.9 years;
M for controls, across the seven studies that reported this
statistic, was 7.4 years). Regarding the sex distribution
across the comparison groups, in the six studies that
reported this statistic 369 of the 720 HIV-infected partici-
pants (51%) were female, as were 473 of the 842 unin-
fected controls (56%).
Four studies [39,41,43,44] used the KABC, whereas the
rest used the KABC-II. All adapted the instrument’s admin-
istration and/or scoring to improve its fairness to their
sample. For instance, six [39–41,44–46] did not administer
(or, at least, do not report results related to) the
Achievement and/or Knowledge subtests, which assess
crystallized intelligence and therefore are likely to rely
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Table 1. Study Quality Assessment
Study ID Study Site Study Type Qualitya Confounding Variables Primary Limitations Primary Strengths
Bagenda et al. [39] Uganda Cross-sectional 22 Age, sex, HAZ, WAZ, cranial nerve
function
Potential selection bias noted. None of subjects’ mothers had received
ARVT or been exposed to illicit drugs.
Testers were blinded.
Boivin et al. [40] Uganda Cross-sectional 21 Age, sex, weight, CD4, viral load,
HOME score
Does not describe participant selection
process.
Testers were blinded. KABC-II validated in/
for Uganda. Used local normative data to
compare results.
Boivin et al. [41] Congo Cross-sectional 15 Age, height, weight, head
circumference, arm
circumference, Quaker arm
circumference
Does not report exact p values for the main
outcomes, except where values are <.05/
.01/.0001. Unable to determine if
subjects were representative of the
population from which they were
recruited. Unable to determine attempts
were made to blind those assessing
participants.
Local HEU and HUU control groups used for
statistical comparison of results.
Boivin et al. [47] Multi-siteb Prospective 13 Age, sex, race, height, weight, BMI,
caregiver educational level, who
caregiver is, sibling enrolled in
study
Poster format, hence underreporting of
required information (e.g.
representativeness of sample, whether
testers were blinded, recruitment
procedures, test adaptation).
Multi-site study with large sample size.
Boivin et al. [42] Uganda RCT 21 Age, sex, WAZ, SES, pre-intervention
Cogstate score
Unable to determine if attempts were
made to blind those assessing subjects.
KABC-II validated for children in Ugandan
context.
Brahmbhatt et al.
[43]
Uganda Longitudinal 16 Age, sex, HAZ, WAZ, grade at school Participant loss to follow up not well
described. Unable to determine if those
conducting assessments were blinded.
KABC-II validated for children in Ugandan
context.
Gosling et al. [44] UK Longitudinal 14 CD4, viral load Statistical tests and results/probabilities are
not reported. Unable to determine if loss
to follow-up was taken into account
statistically. Unable to determine if
subjects are representative of the entire
population from which they were
recruited. Small sample size.
Interventions and principal confounders are
clearly described.
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heavily on exposure to the mainstream culture within
which the test was developed [51]. Similarly, five [39–
41,45,46] reported administering the instrument in the
participants’ home language.
Quality assessment
Table 1 presents the findings from our critical evaluation of
the quality of each of the eight studies. Most were rated as
being of relatively higher methodological quality, with all
except one scoring above the mid-point score of 13 on the
Downs and Black checklist, and four scoring more than 20
out of the maximum possible 26. All studies considered
potentially confounding variables (e.g. age, sex, CD4 and
viral loads, and whether participants were cART treated or
cART naïve) in their interpretation of results, and all except
one included such potential confounders in their statistical
analyses. During data extraction, we noted that reporting
limitations primarily related to the selection and recruit-
ment of samples. Hence, we cannot eliminate the possibi-
lity of selection bias based on the information provided in
the articles. We also noted that, in two of the eight studies,
some results were based on data dredging.
KABC/KABC-II identification of HIV-associated cognitive
impairment
Overall, our review suggests that the KABC/KABC-II can be
used successfully across different countries and cultural
contexts to identify cognitive impairment in HIV-infected
children and adolescents. Hence, although there is no cur-
rent consensus regarding whether adult diagnostic criteria
for HIV-associated neurocognitive disorders (HAND) might
be applied to children and adolescents [52], it appears the
KABC/KABC-II might usefully serve, alongside assessments
of functional competency, as a core component of a battery
that describes where along the HAND spectrum HIV-
infected individuals younger than 18 years might be placed.
In each of the reviewed studies, the KABC/KABC-II suc-
cessfully identified cognitive impairment in HIV-infected
children, either relative to uninfected counterparts or to
their own baseline. Eight of the nine studies used local
normative data, or a local reference group, against which
to compare cognitive performance of HIV-infected children.
These studies identified impairment at the group level (i.e.
they classed the performance of the group of HIV-infected
children as “impaired” if there were significant between-
group differences, in favour of the control/normative
group, on the particular subtest or index under considera-
tion). Gosling et al. [44] reported a decline in cognitive
functioning across longitudinal follow-up, but did not spe-
cify (a) whether this decline suggested impairment relative
to healthy controls, or (b) the subtests/scales that formed
the bases for this observation. As Table 2 shows, six studies
reported significant between-group differences on the
Simultaneous Processing index, suggesting that HIV-
infected children might have particular difficulty on visual-
perceptual tests that require them to disintegrate, manip-
ulate, and reintegrate component parts of a whole unit.
Together with the fact that four studies also detected sig-
nificant between-group differences on the SequentialT
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Table 2. Description of study characteristics and findings
nHIV+ (%cART-naïve); nHIV- (% HEU); KABC Domain
M age (yrs); M age (yrs);
Study ID N nfemale (%) nfemale (%) Version Test Adaptations Test Administrator Specific Results
a of Impairment
Bagenda et al. [39] 107 28 (100%); 79 53%); I • Language adapted Child psychometrist • Hand Movements (p = .02) • Visual STM
9.1; 8.7; • Knowledge component not
administered18 (64%) 42 (53%)
Boivin et al. [40] 176 54 (100%); 122 II • Language adapted Native speakers • Seq. Processing • Memory
9.0 (NR); • Knowledge component not
administered
• Sim. Processing • VS
NR NR; • Learning • IR/DR
NR • Planning • EF
Boivin et al. [41] 41 11 (100%); 30 50%); I • Language adapted Local teachers • MPI (p < .0001) • Global
4.6; 2.0; • Only Mental Processing subtests
(except Photo Series)
administered
• NVI (p < .05)
NR NR • Sim. processing (p < .0001)
• Seq. processing (p < .0001)
Boivin et al. [47] 611 246 (0%); 365 (50%); II NR Research assistants • MPI
• NVI (p < .0001)
• Global
7.0; 6.8;
135 (55%) 186 (51%)
Boivin et al. [42] 166 60 (95%); 106 II NR NR • Seq. processing (p < .01) • Memory
9.9; (NR); • Sim. processing (p < .002) • VS
36 (60%) 8.8; • Learning (p = .05) • IR/DR
66 (62%)
Brahmbhatt et al. [43] 370 140 (9%); 230 1%); II • Knowledge component
administered
Nurses and Midwives • Sim. Processing (p = .035) • VS
8.6; 9.9; • Learning (p = .047) • IR/DR
75 53%) 120 2%) • Knowledge (p < .001) • Language
• NVI (p < .001)
Gosling et al. [44] 11 11 36% at Time 1, 0 I • Achievement scale Psychologists NR NR
18% at Time 2); not administered
7.3;
3 (27%)
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Processing index (i.e. on tests that assess the ability to
encode, store, and then organize items of information
into a logical sequence), one might conclude that the cog-
nitive processes involving activity in the posterior regions of
the brain are particularly susceptible to impairment in HIV-
infected children [32,52].
Across all studies, there was no single KABC/KABC-II
subtest or scale on which HIV-infected children performed
consistently poorly. Hence, this review suggests that no
single subtest offers the potential to be adapted into a
stand-alone screening tool. This conclusion is consistent
with research indicating that numerous independent cogni-
tive domains are affected in HIV-infected children [3,53].
Appropriate assessment of these children should therefore
include administration of, at least, Simultaneous Processing,
and Sequential Processing subtests of the KABC/KABC-II,
and should probably include the Planning and Learning
subtests as well.
Our review also demonstrates that the KABC/KABC-II is
sensitive to cognitive impairment in HIV-infected children,
with and without cART, when compared to controls. This
finding is promising because a growing body of research
demonstrates that subtle cognitive impairments may per-
sist even in HIV-infected children who are well controlled
on cART [54–56].
To improve the culture-fairness of the instrument,
researchers across the reviewed studies typically implemen-
ted a three-part strategy: (1) They translated it into the local
language; (2) they excluded either or both the Knowledge
and Achievement components (i.e. those subtests that rely
heavily on crystalized intelligence, or learned, culture-specific
environmental experiences); and (3) where local normative
data were unavailable, they applied either conventional cut-
offs (1 SD below the standardization sample mean), or stricter
cutoffs (2 SD below the mean of a local control group), to
classify impairment, depending on whether standardization
sample data were judged applicable or not.
Finally, we identified an interesting trend in the reviewed
studies: The KABC/KABC-II was not always administered by
a registered or licensed clinical psychologist or neuropsy-
chologist. Rather, administration fell to local teachers,
research assistants, or psychometrists. Although not all of
the manuscripts make it clear, perusal of the author lists
and acknowledgements suggests that these test adminis-
trators all operated under appropriate supervision. In light
of the scarcity of highly-trained professionals in low- and
middle-income countries where HIV is prevalent [39,57], it
is useful to know that the instrument can be administered
by trained lay professionals, with the ethical proviso that
these individuals work (a) according to guidelines offered
by the International Test Commission, (b) under the super-
vision of a qualified expert, and (c) with permission of the
test publisher.
Limitations
The strength of the conclusions one might draw from this
systematic review are limited by the characteristics of the
reviewed studies and by the nature of the reviewed instru-
ment. We therefore offer the following caveats.T
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First, although authors of the included studies noted that
they had translated the instrument from English into the
local language, most did not describe their translation pro-
cedures in detail. So, for example, it is unknown whether
rigorous back-translations procedures were in place, and
whether community members were consulted about idio-
matic aspects of the translation. The absence of this infor-
mation raises questions around linguistic equivalence of the
various translated versions of the KABC/KABC-II.
Second, no KABC/KABC-II subtest measures the cognitive
construct of information processing speed directly. This limits
the value of the instrument in assessment of HIV-infected
children in different countries and cultural contexts, given
that (a) strong recent evidence suggests that processing
speed is an important component of HANI [53], and (b) there
are cross-cultural differences in the rate at which processing
speed matures and develops across childhood and adoles-
cence [58].
Third, HIV-1 subtype distribution is not consistent across the
globe [7], and so the studies reviewed here were not focused
on cognitive impairment associated with a single clade type.
For instance, the studies in Central and East Africa likely
included a predominance of clade A-infected children, whereas
those conducted in sub-Saharan Africa likely included a pre-
dominance of clade C-infected children. Hence, one must exer-
cise caution when generalizing these findings because of the
possibility that clade-specific neuropathogenic differences
might manifest in differing degrees of disease severity
[40,59,60].
Conclusions
The findings of this review suggest that the KABC/KABC-II
has cross-cultural utility. It appears that the instrument can
provide comprehensive information regarding cognitive
impairment in HIV-infected children, regardless of the
country or cultural context in which it is administered.
The instrument is especially useful because it can be admi-
nistered by laypersons, and because it is sensitive enough
to identify impairment in children who are otherwise well
managed (i.e. who are clinically stable on cART). However,
the review also highlights the need for more cross-cultural
validity studies of the KABC/KABC-II, and, particularly, for
research investigating whether the instrument is sensitive
to clade-specific variations in cognitive impairment. In such
future research (and, indeed, in any research using the
KABC/KABC-II with HIV-infected children), we suggest that
the adaptation procedures described in the studies
reviewed here be used as a baseline to ensure culture-fair
testing. We further recommend that, when adapting test
material, researchers apply the standard procedures set out
by the International Test Commission [61,62], and that they
describe all adaptations clearly in the published material.
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